Jeffrey D Marrazzo insider trades

Open-market stock purchases and sales by Jeffrey D Marrazzo, Director at Prime Medicine, Inc, from SEC Form 4 filings since Mar 16, 2015.

Recent trades

DateStockTradeValue
Jun 5, 2026PRME Prime Medicine, IncBought (not open market)—

Companies traded

  • PRME Prime Medicine, Inc: other filings, last Jun 5, 2026
  • ONCE Spark Therapeutics, Inc: 41 sales, last Dec 17, 2019

Get free alerts when Jeffrey D Marrazzo files a new trade →